Novo Nordisk

Company ● Covered in 2 stories + Follow ✴ AI Graph Claim this company

Novo Nordisk is tracked in TLDRocket’s company dataset. Explore the recorded developments, relationships and supporting evidence below. Coverage reflects our monitored sources and may be incomplete.

Signals

1 story (+0%)

Media momentum

As of 6 Nov 2026 · Visible stories in the last 30 days, compared with the 30 days before.

2 sources

Source diversity

As of 6 Nov 2026 · Distinct publications behind this entity's visible coverage.

—

Release activity

As of 6 Nov 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.

1 event

Funding signals

As of 6 Nov 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.

Sep 2026 → Oct 2026

Coverage span

As of 6 Nov 2026 · First to most recent month of TLDRocket coverage of this entity.

Management records

updated 21 Sep 2026

Observed in public listings; this is not a verified current management roster.

  • Anonymous President & CEO
  • Tania Sabroe Executive Vice President, People, Organisation & Corporate Affairs
  • Yiannis Mallis Senior Vice President Portfolio Strategy & Access
  • Jamey Millar Executive Vice President, US Operations
  • Hong Chow Executive Vice President, Product & Portfolio Strategy
  • Anja Jørgensen Vice President - Head of the Corporate Ombudsman Function
  • Martin Holst Lange Executive Vice President of R&D & Chief Scientific Officer
  • Alan Moses Senior Vice President And Global Chief Medical Officer
  • Doug Langa Executive Vice President & Senior VP, Head of North America Operations and President of NNI
  • Karsten Munk Knudsen Executive Vice President, Chief Financial Officer
  • Steven Benz Corporate Vice President, General Counsel, Novo Nordisk Inc., US Operations
  • Kasper Bødker Mejlvang Executive Vice President, CMC & Product Supply

+ 18 more tracked

View 12-month management history

Latest developments

Acquisition: OpenAI & Orchestra Bio TechCrunch · 2 weeks ago · 1 Market development: Cellular Intelligence & Moderna Fortune · 1

Timeline

Month Quarter Year

October 2026

Acquisition: OpenAI & Orchestra Bio Acquisition

September 2026

Relationships

Products & technology